Shingo Dan

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Circulating Tumor

Endoplasmic Reticulum Stress

Top Venues

Cell death & disease

Pharmacology research & perspectives

This page only lists publications with an associated author ORCID identifier.

Publications

Kazuma Takeuchi, Yumiko Nishimura, Takayoshi Matsubara, Sho Isoyama, Asuka Suzuki, Masaaki Matsuura, Shingo Dan
Prediction of cell cycle distribution after drug exposure by high content imaging analysis using low-toxic DNA staining dye. Pharmacology research & perspectives 12 (3) (2024)
Yukiko Kojima, Saki Fujieda, Liya Zhou, Masahiro Takikawa, Kouji Kuramochi, Toshiki Furuya, Ayaka Mizumoto, Noritaka Kagaya, Teppei Kawahara, Kazuo Shin-Ya, Shingo Dan, Akihiro Tomida, Fuyuki Ishikawa, Mahito Sadaie
Cytochrome P450 2J2 is required for the natural compound austocystin D to elicit cancer cell toxicity. Cancer science (2024)
Kazuma Takeuchi, Yumiko Nishimura, Takayoshi Matsubara, Sho Isoyama, Asuka Suzuki, Masaaki Matsuura, Shingo Dan
Prediction of cell cycle distribution after drug exposure by high content imaging analysis using low-toxic DNA staining dye. Pharmacology research & perspectives 12 (3) (2024)
Sho Isoyama, Naomi Tamaki, Yutaka Noguchi, Mutsumi Okamura, Yuki Yoshimatsu, Tadashi Kondo, Takeshi Suzuki, Shin-Ichi Yaguchi, Shingo Dan
Subtype-selective induction of apoptosis in translocation-related sarcoma cells induced by PUMA and BIM upon treatment with pan-PI3K inhibitors. Cell death & disease 14 (2) (2023)
Sho Isoyama, Naomi Tamaki, Yutaka Noguchi, Mutsumi Okamura, Yuki Yoshimatsu, Tadashi Kondo, Takeshi Suzuki, Shin-Ichi Yaguchi, Shingo Dan
Subtype-selective induction of apoptosis in translocation-related sarcoma cells induced by PUMA and BIM upon treatment with pan-PI3K inhibitors. Cell death & disease 14 (2) (2023)
Sho Isoyama, Naomi Tamaki, Yutaka Noguchi, Mutsumi Okamura, Yuki Yoshimatsu, Tadashi Kondo, Takeshi Suzuki, Shin-Ichi Yaguchi, Shingo Dan
Subtype-selective induction of apoptosis in translocation-related sarcoma cells induced by PUMA and BIM upon treatment with pan-PI3K inhibitors. Cell death & disease 14 (2) (2023)
Sho Isoyama, Naomi Tamaki, Yutaka Noguchi, Mutsumi Okamura, Yuki Yoshimatsu, Tadashi Kondo, Takeshi Suzuki, Shin-Ichi Yaguchi, Shingo Dan
Subtype-selective induction of apoptosis in translocation-related sarcoma cells induced by PUMA and BIM upon treatment with pan-PI3K inhibitors. Cell death & disease 14 (2) (2023)
Doudou Zhang, Takashi Shimokawa, Qianqian Guo, Shingo Dan, Yoshio Miki, Shigeaki Sunada
Discovery of novel DNA-damaging agents through phenotypic screening for DNA double-strand break. Cancer science (2022)
Naoyuki Nishiya, Yusuke Oku, Chie Ishikawa, Tsutomu Fukuda, Shingo Dan, Tetsuo Mashima, Masaru Ushijima, Yoko Furukawa, Yuka Sasaki, Keishi Otsu, Tomoko Sakyo, Masanori Abe, Honami Yonezawa, Fumito Ishibashi, Masaaki Matsuura, Akihiro Tomida, Hiroyuki Seimiya, Takao Yamori, Masatomo Iwao, Yoshimasa Uehara
Lamellarin 14, a derivative of marine alkaloids, inhibits the T790M/C797S mutant epidermal growth factor receptor. Cancer science 112 (5) (2021)